1-6 of 6
anti-allergic agents
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Amlexanox As a Possible Breakthrough Drug for MLL/AF4 -Positive Acute Lymphoblastic Leukemia

Hayato Tamai, MD PhD, Hiroki Yamaguchi, MD PhD, Koichi Miyake, MD PhD, Miyuki Takatori, Tomoaki Kitano, Syunsuke Yui, MD, Keiko Fukunaga, MD, Kazutaka Nakayama, MD PhD, Koiti Inokuchi, PhD MD
Journal: Blood
Blood (2016) 128 (22): 1590.
https://doi.org/10.1182/blood.V128.22.1590.1590
Published: 2016
Journal Articles

Skin Rash with Eosinophilia Resulting from Bendamustine Plus Rituximab Treatment: A Hematological and Pathological Analysis of 5 Cases

Tatsuro Jo, MD PhD, Kensuke Horio, MD, Kazuto Shigematsu, MD PhD, Fumi Toriyama, MD
Journal: Blood
Blood (2014) 124 (21): 5376.
https://doi.org/10.1182/blood.V124.21.5376.5376
Published: 2014
Journal Articles

L-Asparaginase Allergic Patients Treated with L-Asparaginase Loaded into Red Blood Cells in an Expanded Access Program. Report of Four Cases

Audrey Contet, MD, Severine Lissandre, MD, Céline Berthon, MD PhD, Yann Godfrin, PhD, Yves Bertrand, MD
Journal: Blood
Blood (2014) 124 (21): 937.
https://doi.org/10.1182/blood.V124.21.937.937
Published: 2014
Journal Articles

L-Asparaginase Monotherapy in Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma, Nasal Type: Results of A Phase II Study.

Ye Guo, Xuejun Ma, Zuguang Xia, Kai Xue, Qunling Zhang, Xiaonan Hong
Journal: Blood
Blood (2012) 120 (21): 2730.
https://doi.org/10.1182/blood.V120.21.2730.2730
Published: 2012
Journal Articles

Dasatinib (BMS354825) Inhibits IgE-Dependent Activation and Histamine Release in Human Blood Basophils.

Michael Kneidinger, MD, Peter Valent, MD, Karoline V. Gleixner, MD, Stefan Florian, MD, Alexandra Boehm, MD, Karoline Sonneck, MD, Margit Weghofer, Christian Lupinek, Susanne Vrtala, MD, Anja Vales, MD, Rudolf Valenta, MD, Giulio Superti-Furga, PhD, Francis Y. Lee, PhD
Journal: Blood
Blood (2006) 108 (11): 1365.
https://doi.org/10.1182/blood.V108.11.1365.1365
Published: 2006
Journal Articles

Risk Reduction of Chronic Graft Versus Host Disease by Anti-CD20 Treatment (Rituximab).

Marlies E.H.M. Van Hoef, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5567.
https://doi.org/10.1182/blood.V106.11.5567.5567
Published: 2005